BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Chinese Patent Office
Boehringer Ingelheim

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,598,089

« Back to Dashboard

Summary for Patent: 4,598,089

Title: Leucine derivatives
Abstract:Novel compounds of the formula ##STR1## wherein A signifies the group ##STR2## or --(CH.sub.2).sub.5 --, which inhibit pancreas lipase and can be used for the control or prevention of obesity and hyperlipaemia, are disclosed. The inventive compounds can be produced by the cultivation of microorganism Streptomyces toxytricini, identified as NRRL 15443.
Inventor(s): Hadvary; Paul (Biel-Benken, CH), Hochuli; Erich (Arisdorf, CH), Kupfer; Ernst (Basel, CH), Lengsfeld; Hans (Reinach, CH), Weibel; Ernst K. (Pratteln, CH)
Assignee: Hoffmann-La Roche Inc. (Nutley, NJ)
Application Number:06/621,827
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Formulation; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,598,089

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland3415/83Jun 22, 1983

International Patent Family for Patent: 4,598,089

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria30025► Subscribe
Australia2947884► Subscribe
Australia572851► Subscribe
Bulgaria60766► Subscribe
Canada1247547► Subscribe
Germany19875045► Subscribe
Germany3466538► Subscribe
Denmark160496► Subscribe
Denmark308584► Subscribe
European Patent Office0129748► SubscribeSPC/GB98/044United Kingdom► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Boehringer Ingelheim
Cantor Fitzgerald
Farmers Insurance
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus